Land & Buildings Investment Management’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.7M Sell
1,011,002
-42,204
-4% -$2.09M 8.06% 3
2025
Q4
$49.6M Sell
1,053,206
-98,747
-9% -$4.58M 8.24% 3
2025
Q3
$48.4M Buy
1,151,953
+72,800
+7% +$2.93M 8.88% 1
2025
Q2
$39.6M Sell
1,079,153
-67,850
-6% -$2.25M 7.91% 1
2025
Q1
$34.8M Sell
1,147,003
-412,201
-26% -$11.9M 7.35% 3
2024
Q4
$44.3M Buy
1,559,204
+34,189
+2% +$920K 8.98% 1
2024
Q3
$39.8M Sell
1,525,015
-272,385
-15% -$5.31M 8.14% 2
2024
Q2
$26.3M Buy
1,797,400
+290,740
+19% +$4.11M 6.18% 7
2024
Q1
$22.2M Buy
+1,506,660
New +$20.7M 4.87% 10

Other funds holding AHR

Land & Buildings Investment Management's AHR Position: Q1 2026 in Review

Land & Buildings Investment Management reduced its American Healthcare REIT (AHR) stake by 4% in Q1 2026, selling an estimated $2.09M and leaving 1,011,002 shares worth $47.7M. The position accounts for 8.06% of the portfolio, ranked #3.

Land & Buildings Investment Management first reported a position in AHR in Q1 2024 and has held it in 9 quarters since. The position peaked at $49.6M in Q4 2025. 518 funds tracked by Wall St. Rank hold AHR as of Q1 2026.

  • Land & Buildings Investment Management held 1,011,002 shares of American Healthcare REIT worth $47.7M as of Q1 2026.
  • Land & Buildings Investment Management sold 42,204 American Healthcare REIT shares in Q1 2026, an estimated $2.09M.
  • American Healthcare REIT made up 8.06% of Land & Buildings Investment Management's portfolio in Q1 2026, its #3 holding.
  • Land & Buildings Investment Management first reported a position in American Healthcare REIT in Q1 2024 and has held it in 9 quarters since.
  • Land & Buildings Investment Management's American Healthcare REIT position peaked at $49.6M in Q4 2025.
  • 518 funds tracked by Wall St. Rank held American Healthcare REIT as of Q1 2026.

Based on Land & Buildings Investment Management's 13F filing for Q1 2026, filed 15 May 2026.